Danziger Asaf (CIK 1654435) reported 3 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-01). Recent activity: Buy NVCR (268 shares), Buy NVCR (1 shares), Buy NVCR (833 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-01 | NovoCure Ltd (NVCR) | Director | Buy | 268 | $2,988 |
| 2026-01-08 | NovoCure Ltd (NVCR) | Director | Buy | 1 | $11 |
| 2025-07-01 | NovoCure Ltd (NVCR) | Director | Buy | 833 | $12,603 |
Source: SEC Form 4 filings · as of 2026-07-01